Literature DB >> 31177109

Traditional Chinese Medicine (TCM) Astragalus Membranaceus and Curcuma Wenyujin Promote Vascular Normalization in Tumor-derived Endothelial Cells of Human Hepatocellular Carcinoma.

Wenhua Zang1,2, Hua Bian3,2, Xianzhang Huang1,2, Gang Yin4, Chaoyun Zhang1,2, L I Han1,2, Pengfei Hao1,2, Shengchen Ding1,2, Y U Sun5, Zhijian Yang5,6, Robert M Hoffman6,7, Decai Tang8.   

Abstract

BACKGROUND/AIM: The aim of the present study was to investigate the vascular normalization effect of traditional Chinese medicine Astragalus membranaceus (AM) and Curcuma wenyujin (CW) on tumor-derived endothelial cells (TECs).
MATERIALS AND METHODS: TECs were isolated from the xenografted HCC cell line HepG2 expressing red fluorescent protein (RFP). The effect of AM and CW on TECs proliferation was measured using the CCK8 assay. The vascular normalization potential of AM and CW was assessed using a tube formation assay. Immunocytochemistry was performed to assess the effect of AM and CW on the expression of angiogenic maker CD34 and hypoxia-inducible factor HIF1a.
RESULTS: The isolated TECs and endothelioma (EOMA) cells did not differ with regard to the expression levels of endothelial markers CD34, VEGFR-1, VEGFR-2, PDGFR-α and PDGFR-β. All AM, CW, AM+CW and Nintedanib (Nin) showed a dose-dependent increasing inhibition effect on either TECs or EOMA cells. AM, CW and AM+CW significantly reduced HIF1a expression, increased CD34 expression and enhanced endothelial network formation in TECs or EOMA cells compared to the control.
CONCLUSION: AM and CW promoted vascular normalization in tumor-derived endothelial cells of HCC, through increased expression of CD34 and reduced expression of HIF1a. Copyright
© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Astragalus membranaceus; Curcuma wenyujin; HCC; agiogenesis; vascular normalization

Mesh:

Substances:

Year:  2019        PMID: 31177109     DOI: 10.21873/anticanres.13400

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

Review 1.  Stem Cell Therapy for Hepatocellular Carcinoma: Future Perspectives.

Authors:  Hoda Elkhenany; Ahmed Shekshek; Mohamed Abdel-Daim; Nagwa El-Badri
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

2.  Sutureless Surgical Orthotopic Implantation Technique of Primary and Metastatic Cancer in the Liver of Mouse Models.

Authors:  Hiroto Nishino; Hannah M Hollandsworth; Norihiko Sugisawa; Jun Yamamoto; Yoshihiko Tashiro; Sachiko Inubushi; Kazuyuki Hamada; Y U Sun; Hyein Lim; Siamak Amirfakhri; Filemoni Filemoni; Robert M Hoffman; Michael Bouvet
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

3.  System Pharmacology-Based Strategy to Decode the Synergistic Mechanism of GanDouLing for Wilson's Disease.

Authors:  Juan Zhang; Hong Chen; Yuancheng Bao; Daojun Xie; Wenming Yang; Huaizhou Jiang; Ting Dong; Hui Han
Journal:  Evid Based Complement Alternat Med       Date:  2021-01-29       Impact factor: 2.629

Review 4.  Current Perspective of Traditional Chinese Medicines and Active Ingredients in the Therapy of Hepatocellular Carcinoma.

Authors:  Yuyao Li; Yue Li; Jinghao Zhang; Longshan Ji; Man Li; Xuehua Sun; Hai Feng; Zhuo Yu; Yueqiu Gao
Journal:  J Hepatocell Carcinoma       Date:  2022-02-09

5.  Huxie Huaji Ointment Induced Apoptosis of Liver Cancer Cells In Vivo and In Vitro by Activating the Mitochondrial Pathway.

Authors:  Yuan Cai; Qing Du; Tian-Hao Deng; Bing-Bing Shen; Yan-Mei Peng; Pu-Hua Zeng; Song-Ren Yu
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-15       Impact factor: 2.629

6.  Xiaoai Jiedu Recipe suppresses hepatocellular carcinogenesis through the miR-200b-3p /Notch1 axis.

Authors:  Wenli Qiu; Zhongqiu Wang; Rong Chen; Haibo Shi; Yanxia Ma; Hongli Zhou; Muhan Li; Wenting Li; Haibin Chen; Hongguang Zhou
Journal:  Cancer Manag Res       Date:  2020-11-02       Impact factor: 3.989

Review 7.  The roles and mechanisms of hypoxia in liver fibrosis.

Authors:  Jingyao Cai; Min Hu; Zhiyang Chen; Zeng Ling
Journal:  J Transl Med       Date:  2021-05-01       Impact factor: 8.440

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.